Please wait...
About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
Rapid Detection of Tuberculosis -SCSU-New Haven iGEM
The World Health Organization reports 9.6 million new Tuberculosis cases in 2014. As a global health issue...
Can cattle ventilate effectively while tilted in a chute and receiving veterinary care?
Cattle are commonly presented to veterinarians for routine and emergent medical procedures. Lower limbs...